Kinnear Pharmaceuticals https://validator.w3.org/feed/docs/rss2.html Attribution Contact Us Our Work Colistin Resistance on the Rise home leadership leadership_bio header Published Research Shows CSA-131’s Potent Efficacy against Global Health Threat Home news pipeline science overview Contact_new FDA grants QIDP Designation For Kinnear’s CSA-131 drug for Life-threatening Pseudomonas Bacterial Infections in CF CSA-131 Highly Effective against Colistin-resistant Strains Footer